MAPK15 Antibody (N-term) Blocking peptide

Artikelnummer: ABT-BP7554A
Artikelname: MAPK15 Antibody (N-term) Blocking peptide
Artikelnummer: ABT-BP7554A
Hersteller Artikelnummer: BP7554a
Alternativnummer: ABT-BP7554A-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: Mitogen-activated protein kinase 15, MAP kinase 15, MAPK 15, Extracellular signal-regulated kinase 7, ERK-7, Extracellular signal-regulated kinase 8, ERK-8, MAPK15, ERK7, ERK8
The ERKs are a subfamily of the MAPKs that have been implicated in cell growth and differentiation. Extracellular signal-regulated kinase 8 (Erk8) is a large MAP kinase whose activity is controlled by serum and the c-Src non-receptor tyrosine kinase. ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5 and can negatively regulate transcriptional co-activation of androgen receptor and GRalpha by Hic-5 in a kinase-independent manner, suggesting a broader role for ERK8 in the regulation of nuclear receptors beyond estrogen receptor alpha. Erk8 is a novel effector of RET/PTC3 and, therefore, RET biological functions.
NCBI: 225689
UniProt: Q8TD08
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP7554a was selected from the N-term region of human ERK8. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.